ArticleJournal for immunotherapy of cancer2016

Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning.

Michelle H Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.